中华骨质疏松和骨矿盐疾病杂志
中華骨質疏鬆和骨礦鹽疾病雜誌
중화골질소송화골광염질병잡지
CHINESE JOURNAL OF OSTEOPOROSIS AND BONE MINERAL RESEARCH
2014年
3期
250-257
,共8页
王雪鹏%李茂强%边振宇%季成%何齐芳%姚旺祥%朱六龙
王雪鵬%李茂彊%邊振宇%季成%何齊芳%姚旺祥%硃六龍
왕설붕%리무강%변진우%계성%하제방%요왕상%주륙룡
PI3K/Akt信号通路%骨髓间充质干细胞%细胞增殖%成骨分化
PI3K/Akt信號通路%骨髓間充質榦細胞%細胞增殖%成骨分化
PI3K/Akt신호통로%골수간충질간세포%세포증식%성골분화
PI3K/Akt signaling pathway%mesenchymal stem cells%cells proliferation%osteogenic differentiation
目的:研究PI3K/Akt信号通路抑制剂LY294002对骨髓间充质干细胞( mesenchymal stem cells , MSCs)增殖及分化的影响。方法采用贴壁法体外分离人骨髓间充质干细胞( hMSCs),加入PI3K抑制剂LY294002(1、10μmol/L),应用MTT法测定细胞增殖,常规成骨诱导分化培养3或7 d,采用碱性磷酸酶( ALP)染色观察成骨分化水平,化学比色法测定ALP活性,茜素红染色后观察矿化钙结节数量并定量分析, Western blot检测磷酸化Akt蛋白表达,应用Realtime-PCR检测各组细胞BMP2、 Runx2、 OPN及Osterix等成骨分化标记物的基因表达水平。结果从24至72 h, LY294002对hMSCs增殖均产生显著抑制,随时间推延,可见抑制增殖效果增强( P<0.05)。 ALP染色和定量测定提示10μmol/L的ALP活性最强,在不同时间显著高于对照组和1μmol/L组( P<0.05)。成骨诱导培养3和7 d,1、10μmol/L组矿化量都显著高于对照组( P<0.05)。10μmol/L组矿化量在成骨诱导7 d也显著高于1μmol/L组( P<0.05)。 Western blot 检测结果证实成骨诱导可激活 Akt 磷酸化蛋白表达,但 LY294002可抑制该蛋白磷酸化。成骨诱导分化7 d,1、10μmol/L均明显促进BMP2、 Runx2、 OPN、 Osterix 4种基因mRNA表达(均P<0.05)。结论 PI3K/Akt信号通路参与hMSCs增殖和分化过程。成骨分化伴随下游Akt蛋白表达。 PI3K抑制剂可抑制hMSCs增殖,但同时促进其向成骨分化和矿化。
目的:研究PI3K/Akt信號通路抑製劑LY294002對骨髓間充質榦細胞( mesenchymal stem cells , MSCs)增殖及分化的影響。方法採用貼壁法體外分離人骨髓間充質榦細胞( hMSCs),加入PI3K抑製劑LY294002(1、10μmol/L),應用MTT法測定細胞增殖,常規成骨誘導分化培養3或7 d,採用堿性燐痠酶( ALP)染色觀察成骨分化水平,化學比色法測定ALP活性,茜素紅染色後觀察礦化鈣結節數量併定量分析, Western blot檢測燐痠化Akt蛋白錶達,應用Realtime-PCR檢測各組細胞BMP2、 Runx2、 OPN及Osterix等成骨分化標記物的基因錶達水平。結果從24至72 h, LY294002對hMSCs增殖均產生顯著抑製,隨時間推延,可見抑製增殖效果增彊( P<0.05)。 ALP染色和定量測定提示10μmol/L的ALP活性最彊,在不同時間顯著高于對照組和1μmol/L組( P<0.05)。成骨誘導培養3和7 d,1、10μmol/L組礦化量都顯著高于對照組( P<0.05)。10μmol/L組礦化量在成骨誘導7 d也顯著高于1μmol/L組( P<0.05)。 Western blot 檢測結果證實成骨誘導可激活 Akt 燐痠化蛋白錶達,但 LY294002可抑製該蛋白燐痠化。成骨誘導分化7 d,1、10μmol/L均明顯促進BMP2、 Runx2、 OPN、 Osterix 4種基因mRNA錶達(均P<0.05)。結論 PI3K/Akt信號通路參與hMSCs增殖和分化過程。成骨分化伴隨下遊Akt蛋白錶達。 PI3K抑製劑可抑製hMSCs增殖,但同時促進其嚮成骨分化和礦化。
목적:연구PI3K/Akt신호통로억제제LY294002대골수간충질간세포( mesenchymal stem cells , MSCs)증식급분화적영향。방법채용첩벽법체외분리인골수간충질간세포( hMSCs),가입PI3K억제제LY294002(1、10μmol/L),응용MTT법측정세포증식,상규성골유도분화배양3혹7 d,채용감성린산매( ALP)염색관찰성골분화수평,화학비색법측정ALP활성,천소홍염색후관찰광화개결절수량병정량분석, Western blot검측린산화Akt단백표체,응용Realtime-PCR검측각조세포BMP2、 Runx2、 OPN급Osterix등성골분화표기물적기인표체수평。결과종24지72 h, LY294002대hMSCs증식균산생현저억제,수시간추연,가견억제증식효과증강( P<0.05)。 ALP염색화정량측정제시10μmol/L적ALP활성최강,재불동시간현저고우대조조화1μmol/L조( P<0.05)。성골유도배양3화7 d,1、10μmol/L조광화량도현저고우대조조( P<0.05)。10μmol/L조광화량재성골유도7 d야현저고우1μmol/L조( P<0.05)。 Western blot 검측결과증실성골유도가격활 Akt 린산화단백표체,단 LY294002가억제해단백린산화。성골유도분화7 d,1、10μmol/L균명현촉진BMP2、 Runx2、 OPN、 Osterix 4충기인mRNA표체(균P<0.05)。결론 PI3K/Akt신호통로삼여hMSCs증식화분화과정。성골분화반수하유Akt단백표체。 PI3K억제제가억제hMSCs증식,단동시촉진기향성골분화화광화。
Objective To study the effect LY294002, a PI3K/Akt signaling pathway inhibitor, on the prolifer-ation and differentiation of human bone mesenchymal stem cells .Methods Human mesenchymal stem cells ( hMSCs ) were isolated by adherent culture and identified .hMSCs were treated with LY294002 , the PI3K specific inhibitor , at two different concentrations , 1 μmol/L or 10 μmol/L, and the cell proliferation was tested by MTT assay .After 3 days or 7 days osteogenic induction culture , osteogenic differentiation was observed by ALP staining and qualification .Alizarin red staining and determination was adopted to analyze mineralization degree .Western blot analysis was employed for Akt phosphorylation .The gene expressions of osteogenic markers , such as BMP2, Runx2, osteopontin and Osterix , were de-termined by Realtime-PCR.Results In non-induction conditions from 24 hours to 72 hours, LY294002 significantly suppressed hMSCs proliferation and the suppressive effect was increased as time went by ( P<0.05 ) .10μmol/L showed the highest ALP activity over the control and 1μmol/L groups in ALP staining and quantitation at 3 days or 7 days osteo-genic induction (P<0.05).Similarly, 1 μmol/L and 10 μmol/L were more extensively calcified than the control in Alizarin red staining and determination after 3 days or 7 days osteogenic induction (P<0.05).At 7 days, 10 μmol/L contained more calcified minerals that 1μmol/L ( P<0.05 ) .Western blot analysis revealed that osteogenic induction stimulated the phosphorylation of Akt which could be inhibited by LY 294002 . At 7 days osteogenic culture , either 1 μmol/L or 10 μmol/L increased the mRNA expression levels of BMP2, Runx2, osteopontin and Osterix (P<0.05). Conclusion PI3K/Akt signaling pathway is involved with the process of proliferation and differentiation in hMSCs .Dur-ing osteogenic differentiation , activation of PI3K/Akt differentially regulates downstream effectors Akt .LY294002 arrests hMSCs proliferation while promots their osteogenic differentiation and subsequent mineralization .